Silence Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $34 | $159 | $224 | $142 |
Gross Profit | 22 | 95 | 139 | 88 |
EBITDA | -12,348 | -20,801 | -22,491 | -28,271 |
EBIT | -12,461 | -20,957 | -22,639 | -28,409 |
Net Income | -11,770 | -20,958 | -27,354 | -28,530 |
Net Change In Cash | 34 | 159 | 224 | 142 |
Free Cash Flow | -17,342 | -10,894 | -21,832 | -12,313 |
Cash | 11,277 | 82,031 | 41,739 | 64,886 |
Basic Shares | 47,231 | 15,744 | 15,744 | 15,742 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $559 | $43,258 | $25,375 | $21,655 |
Gross Profit | 344 | 31,448 | 15,057 | 8,192 |
EBITDA | -89,198 | -48,989 | -49,778 | -60,444 |
EBIT | -89,753 | -49,582 | -50,276 | -61,040 |
Net Income | -88,612 | -45,309 | -43,267 | -50,334 |
Net Change In Cash | 559 | 43,258 | 25,375 | 21,655 |
Free Cash Flow | -62,326 | -67,851 | -39,395 | -57,589 |
Cash | 11,277 | 121,330 | 68,789 | 54,816 |
Basic Shares | 47,231 | 15,416 | 12,364 | 10,731 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.27 |
2025-09-30 | -$0.15 |
2025-06-30 | -$0.55 |
